HDA UK Media and Political Bulletin – 8 July 2021
There was no media coverage today.
Department for Business, Energy & Industrial Strategy, 6 July 2021
The UK aims to be the global leader for development, testing, access, and uptake of new and innovative treatments, medicines and technologies.
There is a focus on four themes which include, developing strategies to tackle future disease following COVID-19, building the science and clinical research infrastructure, supporting innovative technologies in the NHS and establishing a business environment that promotes company growth.
The Vision outlines proposals for immediate action in NHS England together with an ambition to work closely with NHS Scotland and Wales, and Health and Social Care Northern Ireland.
Following the pandemic, there is an opportunity to focus on developing new modes of administering vaccines and tackling the barriers which prevent the scale-up and commercialisation of those novel vaccine formulation technologies.
Additionally, the UK’s departure from the EU provides an opportunity to develop the regulatory environment, recognising the implications of Brexit regarding Northern Ireland and the importance of equity of patient access across the UK.
The recent structural and organisational changes allow for increased collaboration between Government, the NHS and the Life Sciences Sector.
Over the next few years three areas will be prioritised: Processes, systems and people, secondly, partnership, working and system join-up and lastly, regulation in a global context.
For medicines, the Medicines and Healthcare products Regulatory Agency (MHRA) will work with NHS partners and international regulators deliver the world’s leading regulatory model for Digital Health products, which will be a key driver of innovation in the next decade.
The Health System will ensure that health data can be safely accessed by regulators, to allow evidence and advanced analytical tools to be used most effectively.
The Life Sciences sector supports the Government’s net zero target with a commitment to reduce their environmental footprint. The Greener NHS Initiative is supporting the NHS and its supply chain to reach net zero by 2045.
The Life Sciences Vision will further support net zero targets through aiming to reduce the need for prolonged treatment and frequent visits to healthcare settings, digitisation of the UK’s regulatory system to reduce paper use and supporting the deployment of green manufacturing technologies.
There was no media coverage today.
From Factory to Pharmacy
As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.See the Infographic
Apply to become a Member
Membership of the HDA guarantees your organisation:
- Access to leading policy and industry forums of debate and discussion
- Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
- Representation on HDA working parties, including the Members’ Liaison Group
- A daily Political and Media Bulletin and HDA Newsletters
- Access to HDA policy documents and all sections of the HDA website
- Branding and marketing opportunities